| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |